Target intelligence / Profile preview

Novel transcript, antisense to CNTNAP5 (ENSG00000286384)

Target
ENSG00000286384
Molecular classification
Other (non-coding RNA, antisense transcript)
01

Overview

ENSG00000286384 refers to a novel, uncharacterized non-coding RNA transcript located antisense to the Contactin-associated protein-like 5 (CNTNAP5) gene on the human genome. Antisense non-coding RNAs can regulate the expression of their sense gene partners through diverse mechanisms, including transcriptional interference, RNA masking, double-stranded RNA-dependent silencing, and chromatin modification[2][4]. There is no published evidence for protein-coding potential, therapeutic relevance, or specific biological function of this transcript in humans.\n\nKey context and rationale:\n- This entry appears to be a genome annotation artifact or a reference to a transcriptomic finding from large-scale sequencing, not a defined molecular target.\n- Antisense RNAs broadly modulate gene regulation and may influence the stability, splicing, or chromatin architecture of their partner genes, but individual transcripts like ENSG00000286384 are rarely therapeutically targeted and typically lack detailed characterization[2][4].\n- CNTNAP5, the sense gene, encodes a neuronal cell adhesion protein and has been studied in neurodevelopmental contexts, but "novel transcript, antisense to CNTNAP5" does not refer to a protein or functional RNA with established clinical implications.\n- Searches return no evidence this transcript is used as a target for drugs, diagnostics, or therapeutics.\n\nSummary:\nENSG00000286384 is not an established molecular target. It represents an uncharacterized antisense RNA with no current evidence for protein-coding potential, disease association, or pharmacological relevance. The provided name, description, and function are correct for transcriptomic annotation, but not for target discovery or pharmacology.

Other names
antisense RNA to CNTNAP5CNTNAP5-ASENSG00000286384
02

Biological functions

May participate in regulation of gene expression through antisense mechanisms, such as chromatin modification, RNA interference, or modulation of mRNA stability and splicing[2][4]. However, for this specific transcript, there is no published functional data.

Beyond the preview

Go deeper on Novel transcript, antisense to CNTNAP5 (ENSG00000286384).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CNTNAP5 (ENSG00000286384).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call